NCT01367522View on ClinicalTrials.gov

Pharmacokinetics, Safety, and Tolerability of Methylnaltrexone in Volunteers With Impaired Hepatic Function

PHASE1CompletedINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

March 31, 2004

Primary Completion Date

July 31, 2004

Study Completion Date

July 31, 2004

Conditions
Liver Dysfunction
Interventions
DRUG

SC Methylnaltrexone (MNTX)

Trial Locations (1)

10591

Progenics Pharmaceuticals, Inc., Tarrytown

All Listed Sponsors
lead

Bausch Health Americas, Inc.

INDUSTRY

NCT01367522 - Pharmacokinetics, Safety, and Tolerability of Methylnaltrexone in Volunteers With Impaired Hepatic Function | Biotech Hunter | Biotech Hunter